Latest news
OSR Health re-elects board and approves key proposals at annual meeting - Investing.comInvesting.com · Mon, 10 Aug 2026 15:15:00 GMTOSR Health, Inc. (OSRH) Stock Price, News, Quote & History - ca.finance.yahoo.comca.finance.yahoo.com · Sat, 08 Aug 2026 13:48:24 GMTOSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program - Newswire.comNewswire.com · Fri, 07 Aug 2026 19:04:17 GMTVaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform - The Joplin GlobeThe Joplin Globe · Mon, 03 Aug 2026 13:06:28 GMTVaximm Announces VXM01 Glioblastoma Data Publication Plans - ACCESS NewswireACCESS Newswire · Mon, 03 Aug 2026 13:02:39 GMTVaximm's Two Glioblastoma Studies Had No Dose-Limiting Toxicities - Stock TitanStock Titan · Mon, 03 Aug 2026 13:02:00 GMTOSRH|OSR Holdings Inc|Price:0.467|Chg%:+0.021 - TradingKeyTradingKey · Thu, 30 Jul 2026 07:00:00 GMT